{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:11Z","timestamp":1793170031196,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Medical University Startup Fund for Scientific Research","award":["2022QH2032"],"award-info":[{"award-number":["2022QH2032"]}]},{"name":"National Natural Science Foundation of Fujian Province","award":["2022J02032"],"award-info":[{"award-number":["2022J02032"]}]},{"name":"Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare","award":["2023WJWZQN02"],"award-info":[{"award-number":["2023WJWZQN02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28773-1","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:23:42Z","timestamp":1767018222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel m5C-dependent post-transcriptional regulation of KIF11 drives lymphatic metastasis in gastric cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruofan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"28773_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"28773_CR2","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.21.02745","volume":"40","author":"YX Gwee","year":"2022","unstructured":"Gwee, Y. X. et al. Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis. J. Clin. Oncol. 40, 2830 (2022).","journal-title":"J. Clin. Oncol."},{"key":"28773_CR3","first-page":"874","volume":"49","author":"CY Chen","year":"2002","unstructured":"Chen, C. Y. et al. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma. Hepatogastroenterology 49, 874\u2013877 (2002).","journal-title":"Hepatogastroenterology"},{"key":"28773_CR4","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/BF02573892","volume":"9","author":"WJ Hyung","year":"2002","unstructured":"Hyung, W. J., Lee, J. H., Choi, S. H., Min, J. S. & Noh, S. H. Prognostic impact of lymphatic and\/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann. Surg. Oncol. 9, 562\u2013567 (2002).","journal-title":"Ann. Surg. Oncol."},{"key":"28773_CR5","first-page":"3409","volume":"15","author":"T Zhu","year":"2018","unstructured":"Zhu, T., Hu, X., Wei, P. & Shan, G. Molecular background of the regional lymph node metastasis of gastric cancer. Oncol. Lett. 15, 3409\u20133414 (2018).","journal-title":"Oncol. Lett."},{"key":"28773_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/cells10030627","volume":"10","author":"H Zhou","year":"2021","unstructured":"Zhou, H., Lei, P.-J. & Padera, T. P. Progression of Metastasis through Lymphatic System. Cells 10, 627 (2021).","journal-title":"Cells"},{"key":"28773_CR7","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00280-016-3134-3","volume":"78","author":"MW Saif","year":"2016","unstructured":"Saif, M. W. et al. Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856\/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer. Cancer Chemother. Pharmacol. 78, 815\u2013824 (2016).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"28773_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/0300891620988342","volume":"108","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. High KIF11 expression is associated with poor outcome of NSCLC. Tumori 108, 40\u201346 (2022).","journal-title":"Tumori"},{"key":"28773_CR9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1038\/aps.2011.130","volume":"32","author":"XD Sun","year":"2011","unstructured":"Sun, X. D. et al. Dimethylenastron suppresses human pancreatic cancer cell migration and invasion in vitro via allosteric inhibition of mitotic kinesin Eg5. Acta Pharmacol. Sin. 32, 1543\u20131548 (2011).","journal-title":"Acta Pharmacol. Sin."},{"key":"28773_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114364","volume":"184","author":"I Garcia-Saez","year":"2021","unstructured":"Garcia-Saez, I. & Skoufias, D. A. Eg5 targeting agents: From new anti-mitotic based inhibitor discovery to cancer therapy and resistance. Biochem. Pharmacol. 184, 114364 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"28773_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1083\/jcb.201303163","volume":"202","author":"Y Wakana","year":"2013","unstructured":"Wakana, Y. et al. Kinesin-5\/Eg5 is important for transport of CARTS from the trans-Golgi network to the cell surface. J. Cell Biol. 202, 241\u2013250 (2013).","journal-title":"J. Cell Biol."},{"key":"28773_CR12","doi-asserted-by":"publisher","first-page":"10816","DOI":"10.1038\/s41598-020-67643-w","volume":"10","author":"E Amjad","year":"2020","unstructured":"Amjad, E., Asnaashari, S., Sokouti, B. & Dastmalchi, S. Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages. Sci. Rep. 10, 10816 (2020).","journal-title":"Sci. Rep."},{"key":"28773_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3892\/ol.2020.12007","volume":"20","author":"R Zhu","year":"2020","unstructured":"Zhu, R., Xue, J., Chen, H. & Zhang, Q. Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis. Oncol. Lett. 20, 145 (2020).","journal-title":"Oncol. Lett."},{"key":"28773_CR14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/CMR.0000000000000383","volume":"27","author":"AA Tarhini","year":"2017","unstructured":"Tarhini, A. A. et al. A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma. Melanoma Res. 27, 429\u2013438 (2017).","journal-title":"Melanoma Res."},{"key":"28773_CR15","doi-asserted-by":"publisher","first-page":"nwaa273","DOI":"10.1093\/nsr\/nwaa273","volume":"8","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Sequence- and structure-selective mRNA m(5)C methylation by NSUN6 in animals. Natl. Sci. Rev. 8, nwaa273 (2021).","journal-title":"Natl. Sci. Rev."},{"key":"28773_CR16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi, H., Wei, J. & He, C. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Mol. Cell 74, 640\u2013650 (2019).","journal-title":"Mol. Cell"},{"key":"28773_CR17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen, X. et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol 21, 978\u2013990 (2019).","journal-title":"Nat Cell Biol"},{"key":"28773_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1083\/jcb.200810180","volume":"186","author":"S Hussain","year":"2009","unstructured":"Hussain, S. et al. The nucleolar RNA methyltransferase Misu (NSun2) is required for mitotic spindle stability. J. Cell Biol. 186, 27\u201340 (2009).","journal-title":"J. Cell Biol."},{"key":"28773_CR19","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3390\/ijms23042127","volume":"23","author":"CY Li","year":"2022","unstructured":"Li, C. Y., Brown, S., Mehrara, B. J. & Kataru, R. P. Lymphatics in Tumor Progression and Immunomodulation. Int. J. Mol. Sci. 23, 2127 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"28773_CR20","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.1038\/onc.2011.602","volume":"31","author":"A Alitalo","year":"2012","unstructured":"Alitalo, A. & Detmar, M. Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31, 4499\u20134508 (2012).","journal-title":"Oncogene"},{"key":"28773_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ajhg.2011.12.018","volume":"90","author":"P Ostergaard","year":"2012","unstructured":"Ostergaard, P. et al. Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy. Am. J. Hum. Genet. 90, 356\u2013362 (2012).","journal-title":"Am. J. Hum. Genet."},{"key":"28773_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7150\/ijbs.54074","volume":"17","author":"D Wei","year":"2021","unstructured":"Wei, D. et al. KIF11 promotes cell proliferation via ERBB2\/PI3K\/AKT signaling pathway in gallbladder cancer. Int. J. Biol. Sci. 17, 514\u2013526 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"28773_CR23","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.7150\/jca.52103","volume":"12","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. KIF11 is upregulated in colorectal cancer and silencing of it impairs tumor growth and sensitizes colorectal cancer cells to oxaliplatin via p53\/GSK3\u03b2 signaling. J. Cancer 12, 3741\u20133753 (2021).","journal-title":"J. Cancer"},{"key":"28773_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.02.016","volume":"506","author":"G Jungwirth","year":"2021","unstructured":"Jungwirth, G. et al. KIF11 inhibitors filanesib and ispinesib inhibit meningioma growth in vitro and in vivo. Cancer Lett. 506, 1\u201310 (2021).","journal-title":"Cancer Lett."},{"key":"28773_CR25","doi-asserted-by":"publisher","first-page":"35783","DOI":"10.1074\/jbc.M806860200","volume":"283","author":"M Liu","year":"2008","unstructured":"Liu, M. et al. Parkin regulates Eg5 expression by Hsp70 ubiquitination-dependent inactivation of c-Jun NH2-terminal kinase. J. Biol. Chem. 283, 35783\u201335788 (2008).","journal-title":"J. Biol. Chem."},{"key":"28773_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12920-021-00971-6","volume":"14","author":"Y Yang","year":"2021","unstructured":"Yang, Y. & Xu, X. Bioinformatic identification of hub genes and related transcription factors in low shear stress treated endothelial cells. BMC Med. Genom. 14, 120 (2021).","journal-title":"BMC Med. Genom."},{"key":"28773_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04898-5","volume":"607","author":"S Delaunay","year":"2022","unstructured":"Delaunay, S. et al. Mitochondrial RNA modifications shape metabolic plasticity in metastasis. Nature 607, 593\u2013603 (2022).","journal-title":"Nature"},{"key":"28773_CR28","first-page":"13625","volume":"13","author":"L Meng","year":"2021","unstructured":"Meng, L., Zhang, Q. & Huang, X. Abnormal 5-methylcytosine lncRNA methylome is involved in human high-grade serous ovarian cancer. Am. J. Trans. Res. 13, 13625\u201313639 (2021).","journal-title":"Am. J. Trans. Res."},{"key":"28773_CR29","first-page":"1144","volume":"42","author":"H Zheng","year":"2022","unstructured":"Zheng, H., Zhu, M., Li, W., Zhou, Z. & Wan, X. m(5) C and m(6) A modification of long noncoding NKILA accelerates cholangiocarcinoma progression via the miR-582-3p-YAP1 axis, Liver international\u202f: official journal of the International Association for the Study of the. Liver 42, 1144\u20131157 (2022).","journal-title":"Liver"},{"key":"28773_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/0008-5472.CAN-23-2278","volume":"84","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. SUMOylation-Driven mRNA Circularization Enhances Translation and Promotes Lymphatic Metastasis of Bladder Cancer. Can. Res. 84, 434\u2013448 (2024).","journal-title":"Can. Res."},{"key":"28773_CR31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41392-023-01685-0","volume":"8","author":"X Diao","year":"2023","unstructured":"Diao, X. et al. SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancer. Signal Transduct. Target. Ther. 8, 426 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"28773_CR32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41419-022-04926-2","volume":"13","author":"Q Du","year":"2022","unstructured":"Du, Q. et al. FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis. Cell Death Dis. 13, 488 (2022).","journal-title":"Cell Death Dis."},{"key":"28773_CR33","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1038\/onc.2014.408","volume":"34","author":"I Keklikoglou","year":"2015","unstructured":"Keklikoglou, I. et al. MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes. Oncogene 34, 4867\u20134878 (2015).","journal-title":"Oncogene"},{"key":"28773_CR34","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1007\/s10238-022-00952-8","volume":"23","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Initial clinical and experimental analyses of ALDOA in gastric cancer, as a novel prognostic biomarker and potential therapeutic target. Clin. Exp. Med. 23, 2443\u20132456 (2023).","journal-title":"Clin. Exp. Med."},{"key":"28773_CR35","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/0092-8674(95)90142-6","volume":"83","author":"A Blangy","year":"1995","unstructured":"Blangy, A. et al. Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 83, 1159\u20131169 (1995).","journal-title":"Cell"},{"key":"28773_CR36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/pbc.22056","volume":"53","author":"H Carol","year":"2009","unstructured":"Carol, H. et al. Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program. Pediatr. Blood Cancer 53, 1255\u20131263 (2009).","journal-title":"Pediatr. Blood Cancer"},{"key":"28773_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10637-015-0211-0","volume":"33","author":"PM LoRusso","year":"2015","unstructured":"LoRusso, P. M. et al. First-in-human phase 1 study of filanesib (ARRY-520), a kinesin spindle protein inhibitor, in patients with advanced solid tumors. Invest. New Drugs 33, 440\u2013449 (2015).","journal-title":"Invest. New Drugs"},{"key":"28773_CR38","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye, M., Harada, B. T., Behm, M. & He, C. RNA modifications modulate gene expression during development. Science 361, 1346\u20131349 (2018).","journal-title":"Science"},{"key":"28773_CR39","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.7150\/thno.104713","volume":"15","author":"X Hou","year":"2025","unstructured":"Hou, X. et al. NSUN2-mediated m(5)C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2\/SRSF6\/UAP1 signaling axis. Theranostics 15, 2757\u20132777 (2025).","journal-title":"Theranostics"},{"key":"28773_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2021.628137","volume":"9","author":"TR Damase","year":"2021","unstructured":"Damase, T. R. et al. The Limitless Future of RNA Therapeutics. Fron. Bioen. Biotechnol. 9, 628137 (2021).","journal-title":"Fron. Bioen. Biotechnol."},{"key":"28773_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1089\/nat.2018.0736","volume":"28","author":"AD Springer","year":"2018","unstructured":"Springer, A. D. & Dowdy, S. F. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics. Nucleic Acid Ther. 28, 109\u2013118 (2018).","journal-title":"Nucleic Acid Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28773-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28773-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28773-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:05:27Z","timestamp":1777388727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28773-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28773"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28773-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Clinical specimens were collected from the Department of Gastrointestinal Surgery, the First Affiliated Hospital of Fujian Medical University. The study protocol was approved by the Institutional Ethics Committee of of Fujian Medical University (approval number: 202\u2013166), and was conducted in accordance with the principles outlined in the Declaration of Helsinki. Written informed consent was obtained from all patients prior to their participation. All animal procedures were approved by the Institutional Review Board of Fujian Medical University (Approval number: IACUC FJMU 2023-Y-1139). The study involving animals was conducted following the Basel Declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the manuscript and provided their consent for the submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"44782"}}